05-12-2025 16:09 via drugs.com

Most Speakers at FDA Advisory Committee Meetings Support Drug Approval

FRIDAY, Dec. 5, 2025-- Most speakers attending U.S. Food and Drug Administration (FDA) Human Drug Advisory Committee meetings about new drugs or indications support approval, according to a research letter published online Nov. 24 in JAMA Internal...
Read more »

Pharmaceutical Industry news



Socioeconomic Factors, Comorbidities Tied to Late-Onset Depression in Long-Term Cancer Survivors
Downstream Harms of Gabapentinoid-Diuretic Prescribing Cascade Often Overlooked
AI-Based Ambient Scribes May Reduce Physician Documentation Time, Burnout
FDA Approves Expanded Indication for Jaypirca
ASH: Agent Orange Exposure Linked to Increased Risk for Myelodysplastic Syndrome
ASH: Lifestyle Intervention Feasible During Chemo for Lymphoma
ASH: Few Sickle Cell ED Visits Adhere to Guidelines for Opioid Pain Meds
ASH: No Specific Harms Found for Hydroxyurea Use During Pregnancy
Prepregnancy Eating Disorders Linked to Wheezing, Asthma in Offspring
AES: Antiseizure Medication Failure Elevated for Those With Epilepsy, Depression
Increase in Pediatric Obesity Seen From Before to During Pandemic
Anxiety, Confusion Reported After Notification About Dense Breasts
Cannabis-Linked ED Visits Increased With Exposure to Cannabis Retail Stores
Lung Cancer Screening Rates Improved With Targeting Mammography Participants
Desktop versie